PETALUMA, Calif.--(BUSINESS WIRE)--Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, which is intended to treat infections in chronic and acute wounds, announced today the company will exhibit its latest Microcyn wound care products at DF Con 09 in Los Angeles, California on March 19-21, 2009 (Booth #215).
